.png)
WEEKLY SUMMARY: The Nasdaq is down for the 2nd week in a row
US equity indices ended mixed for the week, as investors weighed inflation data against worries over the recent rise in long-term interest rates. Volumes were generally light. Value stocks handily outperformed growth stocks; the Dow managed a modest gain while the Nasdaq was down (-2%) for the 2nd straight week (1st time since December.). Healthcare outperformed while technology stocks underperformed on worries that rising rates would reduce the value of future profits. Financials stocks sold off briefly on Tuesday morning after Moody’s lowered its credit ratings for 10 small- and mid-cap banks and placed six other entities on downgrade watch. Shares in the sector recovered to some degree as the week progressed, however. On the macro side, US CPI rose 0.2% in July, bringing its y/y increase to 3.2%, a tick below expectations. Meanwhile, US producer prices rose 0.3% in the month, a tick above expectations. The week also brought a somewhat mixed inflation outlook from Federal Reserve officials. US Treasury yields moved higher over the week. European stocks ended little changed while Italy’s government spooks markets with windfall tax on banks. In Asia, Japan’s stock markets rose over a holiday-shortened week. Chinese stocks retreated as mounting evidence that the country’s recovery may have peaked weighed on sentiment. China’s latest inflation data revealed that consumer and producer prices fell in tandem for the 1st time since November 2020, underscoring the weak demand in China.
Disclaimer
This marketing document has been issued by Bank Syz Ltd. It is not intended for distribution to, publication, provision or use by individuals or legal entities that are citizens of or reside in a state, country or jurisdiction in which applicable laws and regulations prohibit its distribution, publication, provision or use. It is not directed to any person or entity to whom it would be illegal to send such marketing material. This document is intended for informational purposes only and should not be construed as an offer, solicitation or recommendation for the subscription, purchase, sale or safekeeping of any security or financial instrument or for the engagement in any other transaction, as the provision of any investment advice or service, or as a contractual document. Nothing in this document constitutes an investment, legal, tax or accounting advice or a representation that any investment or strategy is suitable or appropriate for an investor's particular and individual circumstances, nor does it constitute a personalized investment advice for any investor. This document reflects the information, opinions and comments of Bank Syz Ltd. as of the date of its publication, which are subject to change without notice. The opinions and comments of the authors in this document reflect their current views and may not coincide with those of other Syz Group entities or third parties, which may have reached different conclusions. The market valuations, terms and calculations contained herein are estimates only. The information provided comes from sources deemed reliable, but Bank Syz Ltd. does not guarantee its completeness, accuracy, reliability and actuality. Past performance gives no indication of nor guarantees current or future results. Bank Syz Ltd. accepts no liability for any loss arising from the use of this document.
Related Articles
US equities gave back a portion of the previous week’s gains, as uncertainty over the incoming administration’s policies appeared to continue driving the so-called Trump Trade. Financials and energy shares continue to benefit from hopes for deregulation and merger approvals. Likewise, the price of Bitcoin had surged by nearly a third since the eve of the election, as investors anticipated looser regulation of digital currencies. Conversely, health care shares fell sharply following news that Robert F. Kennedy, Jr., would be Trump’s nominee to head the Health and Human Services Department (HHS). On the macro side, yoy US headline inflation rose for the 1st time since March, from 2.4% to 2.6%. PPI data came in above expectations.